Interleukin-3-Receptor-α in Triple-Negative Breast Cancer (TNBC): An Additional Novel Biomarker of TNBC Aggressiveness and a Therapeutic Target.

Cancers (Basel) · 2022 · PMC9406043 · PMID 36010912

Europe PMC DOI

hedged sentence

0.0890

closest p · 1.8× alpha

0.0890

boldest claim

The sentences

near to significancep = 0.089so close (0.05 < p ≤ 0.1)

The hazard ratio for IL-3Rα-positive samples corresponded to 1.50 (CI = 95% 1.01–2.2; p = 0.04) and was near to significance after multivariate adjustment (hazard ratio = 2.01:0.89–4.89, p = 0.089).

also in 56 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.